Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Gastroenterology. 2023 Mar 21;165(1):252–266. doi: 10.1053/j.gastro.2023.03.206

Appendix Table 1.

Participation in the biorepository by study arm

Randomization Arm
Blood Sample* Screening-Colonoscopy HSgFOBT** Total
Blood Sample 1376 (78.1%) 105 (6.0%) 1481
No Blood Sample 385 (21.9%) 1660 (94.0%) 1945
Total 1761 1762 3423

High sensitivity fecal occult blood test (HSgFOBT)

*

The biospecimens continue being monitored both on-site and remotely 24x7

**

Only participants who had a positive HSgFOBT test were eligible for blood draw at their follow-up colonoscopy